about
Proteoglycans in liver cancerFormation and role of exosomes in cancer.Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinomaIntegration of biological knowledge and gene expression data for biomarker selection: FN1 as a potential predictor of radiation resistance in head and neck cancer.MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cellsElevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients.Interstitial fluid: the overlooked component of the tumor microenvironment?Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.Long-term intravital immunofluorescence imaging of tissue matrix components with epifluorescence and two-photon microscopy.Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyStromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer.Elective orthopedic and cardiopulmonary bypass surgery causes a reduction in serum endostatin levels.Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.Tumor Interstitial Fluid Formation, Characterization, and Clinical ImplicationsCrosstalk between Tumor Cells and Macrophages in Stroma Renders Tumor Cells as the Primary Source of MCP-1/CCL2 in Lewis Lung Carcinoma.Quantitative Image Analysis of Epithelial and Stromal Area in Histological Sections of Colorectal Cancer: An Emerging Diagnostic ToolInduction of Monocyte Chemoattractant Proteins in Macrophages via the Production of Granulocyte/Macrophage Colony-Stimulating Factor by Breast Cancer CellsSecond harmonic generation reveals matrix alterations during breast tumor progressionHarnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast mediaTumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors.Cell surface markers in colorectal cancer prognosis.Exosomes in tumor microenvironment influence cancer progression and metastasis.Therapeutic targeting of hyaluronan in the tumor stroma.Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.The Multiple Roles of Exosomes in Metastasis.Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment.Collagen I fiber density increases in lymph node positive breast cancers: pilot study.Exosomal tetraspanins mediate cancer metastasis by altering host microenvironment.Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: can we use enemy territory at our advantage?
P2860
Q26772304-E73649D7-CF17-4CBD-949A-3A11A95AD806Q30303067-5CD2C930-14F0-4F9B-85F4-F8D65BFCC3D5Q33498941-5C6CD4DA-185A-41E1-BDF0-E7F9365AD5F9Q33719052-EF87C744-AE72-475F-AC4D-0B6F8FC56E9CQ33907195-51BC35E4-D1B0-4770-896D-7AD29502B942Q33954959-F41803FB-ABC8-4090-B132-3FCE9A9C1B43Q33997938-72A54213-246F-40FA-81EC-B02E824E8C88Q34025645-E2D096D8-6033-4690-8EC7-754EDBB4C81AQ34060641-721107FC-02C2-43BF-B065-F7B2A7AFE315Q34171808-A27511D9-374C-4A08-9574-CF196E50E74FQ34242595-385F704B-5963-4B13-931C-1290CA855882Q34256150-3027AA39-B552-43B6-B33D-BEC245CFE754Q34369602-79FE30EA-0225-431C-AE5C-3765F6EF3D1AQ34429766-34A30CB6-929F-49E0-A32D-7B130081241BQ34502988-E17B9795-B5F6-46CF-B72E-D9022A3EAD16Q34634293-9E9F9457-3E76-4A66-A624-ECC53EE8D971Q34775377-8C51CDCE-2A77-401D-81DE-735BB75CE9A1Q35149685-8F61A369-57BD-4189-85C5-311F203FE049Q35182174-0D778B53-0CF4-49B4-B5D2-AB3BEE1E7909Q35646453-82E8D9B6-CB88-4312-9E0C-4E5BA1595DD5Q35782923-0F4AB00B-B03B-437A-8B77-D95C02CD2B1CQ36249513-6FA3268B-2F57-4DF1-9385-AAF19F714B2EQ36480181-7F6DF881-FBF9-40FD-9FF1-EBD71E9EA6E7Q36679133-CDA923E5-2374-4AC7-8701-965AD7B2278BQ37314509-ADFAABF9-84DF-47C6-B02C-2261E466D529Q37507440-2BF0CD63-1DC9-4C66-B203-AE753253DBC0Q37690429-175AF215-FB04-4DDB-AA18-77D67CF50638Q37746085-A5E1A4CE-CCEE-497A-8439-30812EEB892FQ37845669-157A6DF7-AC84-458A-A355-4856371EAD74Q38091978-F2D4D524-DBE9-49DD-AA5A-761B5D0DBF05Q38161392-7F102373-76F2-42E4-AE5A-28DADEAC46F0Q38399495-D9249467-37F1-45F8-A7B7-5E92592F7EB7Q38839374-62D31D1F-BA7D-4ADC-9D42-4FA95244E26FQ38876434-5989C330-95B6-4861-AEC7-C83C1CA2B987Q39061503-D6D6564C-E76F-479B-BFA7-3C94BF2083FEQ39174448-E9C56077-EFD2-4A4B-A7C2-4582794BB906Q39856408-B6C541DA-488E-49AF-9233-FB57422C34B6Q41579374-A7B7575B-EEE7-4FD0-849E-06EE04B3348CQ42085843-5F22D5FF-092D-4939-8463-F9BF778C4D1AQ47115406-7FE03F68-2451-4D95-B91D-AE160592E543
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Tumor stroma derived biomarkers in cancer.
@ast
Tumor stroma derived biomarkers in cancer.
@en
type
label
Tumor stroma derived biomarkers in cancer.
@ast
Tumor stroma derived biomarkers in cancer.
@en
prefLabel
Tumor stroma derived biomarkers in cancer.
@ast
Tumor stroma derived biomarkers in cancer.
@en
P2860
P1476
Tumor stroma derived biomarkers in cancer.
@en
P2860
P2888
P304
P356
10.1007/S10555-008-9175-2
P577
2009-06-01T00:00:00Z